# Peripheral vasoconstriction is not elevated during hyperreactive responses to the cold pressor test: a cross-sectional study

**Authors:** Jon Stavres, Anabelle Vallecillo-Bustos, Sarah Parnell, Ryan S. Aultman, Ta’Quoris A. Newsome, Sydney H. Swafford, Abby T. Compton, Rhett C. Schimpf, Sophia N. Schmidt, Carstell Lee, Austin J. Graybeal

PMC · DOI: 10.3389/fphys.2025.1532992 · 2025-03-12

## TL;DR

This study found that high blood pressure responses to cold exposure are not due to increased narrowing of blood vessels in the limbs.

## Contribution

The study shows hyperreactive blood pressure during cold pressor tests is not linked to greater peripheral vasoconstriction.

## Key findings

- Hyperreactors showed higher blood pressure during the cold pressor test but no greater forearm vasoconstriction.
- Handgrip exercise reduced exaggerated blood pressure responses in hyperreactors during the cold pressor test.
- Hyperreactors had exaggerated blood pressure during handgrip exercise but no changes in forearm blood flow.

## Abstract

Individuals demonstrating increases in systolic systolic blood pressure or diastolic diastolic blood pressure blood pressure of at least 15 mmHg are considered hyperreactors to the cold pressor test (CPT). However, it remains unclear if peripheral vasoconstriction is similarly exaggerated during the CPT in these individuals.

Fifty-five individuals (54.5% non-White, 67.3% female) performed a single-visit study including a 2-min CPT of the foot, a 2-min bout of rhythmic handgrip exercise ([HG] 25% maximal voluntary contraction), and a 2-min combined trial (CPT + HG). Beat-by-beat heart rate (HR), blood pressure, and forearm blood flow (FBF) were continuously recorded, and vascular conductance (FVC) was calculated as FBF/mean arterial pressure (MAP).

Hyperreactors (n = 21) demonstrated exaggerated increases in blood pressure and rate pressure product during the CPT compared to normoreactors (n = 34; all p < 0.001), while no significant differences were observed for ΔFBF (f = 1.33, p = 0.259) or ΔFVC responses (f = 2.10, p = 0.083). Results also indicated a blunted increase in ΔMAP during the CPT + HG trial compared to the CPT only trial in hyperreactors (f = 6.95, p < 0.001), which was not observed in normoreactors (f = 0.982, p = 0.420), and a blunted ΔFVC response during the CPT + HG trial in hyperreactors compared to normoreactors (f = 2.57, p = 0.039). When analyzed separately, the blood pressure responses to HG exercise were also significantly exaggerated in hyperreactors compared to normoreactors (all p < 0.001), while ΔFBF and ΔFVC responses were not (both p ≥ 0.701).

These findings indicate that hyperreactive blood pressure responses to the CPT are not accompanied by increased peripheral vasoconstriction. Moreover, handgrip exercise attenuates hyperreactive blood pressure responses to the CPT.

## Full-text entities

- **Genes:** NPTXR (neuronal pentraxin receptor) [NCBI Gene 23467] {aka NPR}, CHPT1 (choline phosphotransferase 1) [NCBI Gene 56994] {aka CPT, CPT1}
- **Diseases:** CL (MESH:D002971), pain (MESH:D010146), metabolic syndrome (MESH:D024821), hypertension (MESH:D006973), obesity (MESH:D009765), hyperemia (MESH:D006940), hypotensive (MESH:D007022), reactive (MESH:D000275), autonomic and cardiovascular dysfunction (MESH:D002318)
- **Chemicals:** Cholesterol (MESH:D002784), glucose (MESH:D005947), alcohol (MESH:D000438), DO2Hb (-), lipid (MESH:D008055), caffeine (MESH:D002110), oxygen (MESH:D010100), water (MESH:D014867), TRG (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11936792/full.md

---
Source: https://tomesphere.com/paper/PMC11936792